Danaher Co. (DHR) Holdings Trimmed by Quest Investment Management LLC

Quest Investment Management LLC lowered its stake in shares of Danaher Co. (NYSE:DHR) by 78.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,809 shares of the conglomerate’s stock after selling 92,977 shares during the period. Quest Investment Management LLC’s holdings in Danaher were worth $2,547,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. BlackRock Inc. raised its stake in Danaher by 6.2% during the first quarter. BlackRock Inc. now owns 43,526,564 shares of the conglomerate’s stock worth $4,261,685,000 after purchasing an additional 2,542,198 shares during the period. Aristotle Capital Management LLC raised its stake in Danaher by 3.5% during the first quarter. Aristotle Capital Management LLC now owns 4,451,816 shares of the conglomerate’s stock worth $435,877,000 after purchasing an additional 150,343 shares during the period. Epoch Investment Partners Inc. raised its stake in Danaher by 2.1% during the first quarter. Epoch Investment Partners Inc. now owns 3,818,204 shares of the conglomerate’s stock worth $373,840,000 after purchasing an additional 77,733 shares during the period. Franklin Resources Inc. raised its stake in Danaher by 5.0% during the first quarter. Franklin Resources Inc. now owns 2,851,517 shares of the conglomerate’s stock worth $279,220,000 after purchasing an additional 135,292 shares during the period. Finally, Schroder Investment Management Group raised its stake in Danaher by 170.4% during the first quarter. Schroder Investment Management Group now owns 2,756,247 shares of the conglomerate’s stock worth $269,865,000 after purchasing an additional 1,736,876 shares during the period. 76.51% of the stock is currently owned by institutional investors.

A number of equities analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Friday, May 25th. Royal Bank of Canada increased their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Thursday, June 21st. Barclays reaffirmed a “buy” rating and set a $113.00 price target on shares of Danaher in a research note on Friday, April 20th. Finally, Morgan Stanley increased their price objective on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, July 20th. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Danaher presently has an average rating of “Buy” and an average target price of $108.31.

In related news, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the firm’s stock in a transaction on Tuesday, July 31st. The shares were sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the completion of the sale, the insider now directly owns 276,438 shares of the company’s stock, valued at approximately $28,163,503.44. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Daniel L. Comas sold 77,407 shares of the firm’s stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $103.93, for a total transaction of $8,044,909.51. Following the sale, the chief financial officer now directly owns 135,218 shares of the company’s stock, valued at $14,053,206.74. The disclosure for this sale can be found here. Insiders sold 196,875 shares of company stock valued at $20,246,147 in the last three months. Company insiders own 11.90% of the company’s stock.

Danaher opened at $100.33 on Friday, Marketbeat Ratings reports. Danaher Co. has a 52-week low of $79.10 and a 52-week high of $106.08. The firm has a market capitalization of $71.17 billion, a PE ratio of 24.90, a price-to-earnings-growth ratio of 1.95 and a beta of 1.04. The company has a quick ratio of 1.07, a current ratio of 1.50 and a debt-to-equity ratio of 0.41.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, July 19th. The conglomerate reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The company had revenue of $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. During the same quarter in the prior year, the business earned $0.99 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. research analysts anticipate that Danaher Co. will post 4.49 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Recommended Story: What are CEFs?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply